BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Journal Article (Journal Article)

BAALC and ERG expression levels are prognostic markers in younger (< 60 years) cytogenetically normal acute myeloid leukemia (CN-AML) adults; their prognostic impact in older (≥ 60 years) patients requires further investigation. We evaluated pretreatment expression of BAALC and ERG in 158 de novo patients treated on cytarabine/daunorubicin-based protocols. The patients were also characterized for other established molecular prognosticators. Low BAALC and ERG expression levels were associated with better outcome in univariable and multivariable analyses. Expression levels of both BAALC and ERG were the only factors significantly associated with overall survival upon multivariable analysis. To gain biological insights, we derived gene expression signatures associated with BAALC and ERG expression in older CN-AML patients. Furthermore, we derived the first microRNA expression signatures associated with the expression of these 2 genes. In low BAALC expressers, genes associated with undifferentiated hematopoietic precursors and unfavorable outcome predictors were down-regulated, whereas HOX genes and HOX-gene-embedded microRNAs were up-regulated. Low ERG expressers presented with down-regulation of genes involved in the DNA-methylation machinery, and up-regulation of miR-148a, which targets DNMT3B. We conclude that in older CN-AML patients, low BAALC and ERG expression associates with better outcome and distinct gene and microRNA expression signatures that could aid in identifying new targets and novel therapeutic strategies for older patients.

Full Text

Duke Authors

Cited Authors

  • Schwind, S; Marcucci, G; Maharry, K; Radmacher, MD; Mrózek, K; Holland, KB; Margeson, D; Becker, H; Whitman, SP; Wu, Y-Z; Metzeler, KH; Powell, BL; Kolitz, JE; Carter, TH; Moore, JO; Baer, MR; Carroll, AJ; Caligiuri, MA; Larson, RA; Bloomfield, CD

Published Date

  • December 16, 2010

Published In

Volume / Issue

  • 116 / 25

Start / End Page

  • 5660 - 5669

PubMed ID

  • 20841507

Pubmed Central ID

  • PMC3031412

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

Digital Object Identifier (DOI)

  • 10.1182/blood-2010-06-290536


  • eng

Conference Location

  • United States